Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Obesity and asthma: Impact on severity, asthma control and response to therapy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Agreement Between Transcutaneous Monitoring and Arterial Blood Gases During COPD Exacerbation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Comorbidity Clusters and Healthcare Use in Individuals With COPD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Users' Experiences With Home Mechanical Ventilation: A Review of Qualitative Studies

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Socioeconomic Variations in Use of Prescription Medicines for COPD: A Register-Based Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Asthma and Adherence to Inhaled Corticosteroids: Current Status and Future Perspectives

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: the COVID STEROID randomised, placebo-controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Characteristics of COPD Patients Prescribed ICS Managed in General Practice vs. Secondary Care

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Asthma is more prevalent in obese compared with normal weight subjects. Our aim has been to review current knowledge of the impact of obesity on asthma severity, asthma control, and response to therapy.Several studies have shown that overweight and obesity is associated with more severe asthma and impaired quality of life compared with normal weight individuals. Furthermore, obesity is associated with poorer asthma control, as assessed by asthma control questionnaires, limitations in daily activities, breathlessness and wheezing, use of rescue medication, unscheduled doctor visits, emergency department visits, and hospitalizations for acute asthma. Studies of the impact of a high body mass index (BMI) on response to asthma therapy have, however, revealed conflicting results. Most studies show that overweight and obesity is associated with less favorable response to asthma therapy with regard to symptoms, level of FEV(1), fraction of exhaled nitric oxide, and airway responsiveness. Some studies suggest that asthma in the obese patient might be more responsive to leukotriene modifiers, orchestrated by leptin and/or adiponectin derived from adipose tissue, than to inhaled corticosteroids, possibly reflecting differences in the underlying airway inflammation in obese vs. non-obese asthmatics.In conclusion, overweight and obesity is associated with poorer asthma control and, very importantly, overall poorer response to asthma therapy compared with normal weight individuals.
OriginalsprogEngelsk
TidsskriftRespiratory Care
Sider (fra-til)867-873
Antal sider6
ISSN0020-1324
DOI
StatusUdgivet - sep. 2013

ID: 36583329